Rockland Trust CO Abbott Laboratories Transaction History

Rockland Trust CO

$2.01 Billion
Q3 2024

A detailed history of Rockland Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Rockland Trust CO holds 98,165 shares of ABT stock, worth $11.2 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

98,165

Previous 111,747 12.15%

Holding current value

$11.2 Million

Previous $11.6 Million 3.62%

% of portfolio

0.56%

Previous 0.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$100.07 - $118.13 $1.36 Million - $1.6 Million	-13,582 Reduced 12.15%	98,165 $11.2 Million
Q2 2024 Jul 23, 2024	BUY	$100.73 - $112.44 $1.38 Million - $1.54 Million	13,660 Added 13.93%	111,747 $11.6 Million
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $9,199 - $10,160	84 Added 0.09%	98,087 $11.1 Million
Q4 2023 Jan 11, 2024	BUY	$90.19 - $110.4 $553,315 - $677,304	6,135 Added 6.68%	98,003 $10.8 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $128,296 - $153,934	1,343 Added 1.48%	91,868 $8.9 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $708,382 - $789,286	-7,029 Reduced 7.21%	90,525 $9.87 Million
Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $103,640 - $121,990	1,070 Added 1.11%	97,554 $9.88 Million
Q4 2022 Jan 24, 2023	BUY	$95.06 - $111.52 $246,015 - $288,613	2,588 Added 2.76%	96,484 $10.6 Million
Q3 2022 Oct 19, 2022	BUY	$96.76 - $112.03 $182,392 - $211,176	1,885 Added 2.05%	93,896 $9.09 Million
Q2 2022 Jul 13, 2022	BUY	$102.07 - $123.37 $106,152 - $128,304	1,040 Added 1.14%	92,011 $10 Million
Q1 2022 Apr 18, 2022	BUY	$114.02 - $139.04 $761,881 - $929,065	6,682 Added 7.93%	90,971 $10.8 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $89,189 - $109,207	772 Added 0.92%	84,289 $11.9 Million
Q3 2021 Oct 25, 2021	BUY	$116.66 - $129.06 $498,138 - $551,086	4,270 Added 5.39%	83,517 $9.87 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $975,278 - $1.15 Million	9,219 Added 13.16%	79,247 $9.19 Million
Q1 2021 Apr 22, 2021	BUY	$108.84 - $128.23 $592,307 - $697,827	5,442 Added 8.43%	70,028 $8.39 Million
Q4 2020 Jan 04, 2021	SELL	$105.0 - $114.42 $553,455 - $603,107	-5,271 Reduced 7.55%	64,586 $7.07 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $350,523 - $425,684	-3,825 Reduced 5.19%	69,857 $7.6 Million
Q2 2020 Jul 09, 2020	SELL	$76.57 - $98.0 $108,423 - $138,768	-1,416 Reduced 1.89%	73,682 $6.74 Million
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $254,735 - $372,492	4,055 Added 5.71%	75,098 $5.93 Million
Q4 2019 Jan 06, 2020	BUY	$78.51 - $87.4 $2.4 Million - $2.67 Million	30,585 Added 75.6%	71,043 $6.17 Million
Q3 2019 Oct 11, 2019	SELL	$81.84 - $88.74 $20,787 - $22,539	-254 Reduced 0.62%	40,458 $3.28 Million
Q2 2019 Jul 05, 2019	SELL	$72.88 - $85.0 $150,497 - $175,525	-2,065 Reduced 4.83%	40,712 $3.42 Million
Q1 2019 Apr 08, 2019	BUY	$66.22 - $80.06 $346,264 - $418,633	5,229 Added 13.93%	42,777 $3.42 Million
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $583,746 - $661,300	-8,904 Reduced 19.17%	37,548 $2.72 Million
Q3 2018 Oct 05, 2018	SELL	$60.81 - $73.36 $1.55 Million - $1.87 Million	-25,493 Reduced 35.43%	46,452 $3.41 Million
Q2 2018 Jul 06, 2018	SELL	$57.57 - $63.54 $291,073 - $321,258	-5,056 Reduced 6.57%	71,945 $4.39 Million
Q1 2018 Apr 10, 2018	SELL	$56.27 - $63.62 $291,140 - $329,169	-5,174 Reduced 6.3%	77,001 $4.61 Million
Q4 2017 Jan 11, 2018	BUY	$53.68 - $57.47 $156,691 - $167,754	2,919 Added 3.68%	82,175 $4.69 Million
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $3.81 Million - $4.25 Million	79,256	79,256 $4.23 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.

Account

Rockland Trust CO Abbott Laboratories Transaction History